SELENOK and neoplasm: However, the mice in our experiments were followed up to 8 months of age and the Grm1/SELENOK–/– mice continued to exhibit lower levels of tumor formation compared to Grm1/SELENOK+/+ and Grm1/SELENOK+/– littermates for both sexes (Supplementary Video 1).